mdlinx mdlinx

MDLinx E-mail Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 emails at a time.


* From Email: 
* To Email: 
To Email: 
To Email: 
To Email: 
To Email: 
Email Subject Line: 
Comments:

Antibiotic treatment of children with community-acquired pneumonia: Comparison of penicillin or ampicillin versus cefuroxime

Dinur–Schejter Y et al. – In previously healthy children, parenteral penicillin or ampicillin for treatment of non–complicated community–acquired pneumonia (CAP) in–hospital is as effective as cefuroxime, and should remain the recommended first–line therapy.

Methods
  • All children aged 3 months to 2 years with non-complicated CAP treated with penicillin or ampicillin or cefuroxime, admitted during 2003-2008, in the Departments of Pediatrics, Hadassah University Medical Center were included.
  • Presenting signs, symptoms, laboratory findings at presentation, clinical parameters including number of days with IV antibiotics, oxygen treatment, length of hospital stay, change of antibiotics, and clinical course 72hr and 1week after admission, were compared.

Results
  • Of the 319 children admitted for non-complicated CAP, 66 were treated with IV penicillin or ampicillin, 253 with IV cefuroxime.
  • Number of days of IV treatment, days of oxygen requirement, and days of hospitalization were similar (2.36±1.6days vs. 2.59±1.6days, 0.31±1.2days vs. 0.64±1.3days, and 2.67±1.4days vs. 2.96±1.7days, respectively).
  • Treatment failure was not significantly different (7.6% vs. 4.7%).
  • The number of patients who were febrile or required oxygen 72hr after admission was similar (13.0% vs. 16.5% and 8.7% vs. 20.9%, respectively).
  • One week after admission no difference between the two groups was seen.
[more...]

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close